What is the generic name?

ALOGLIPTIN

What is the Trade Name for ALOGLIPTIN?

Nesina

What are the Indications for ALOGLIPTIN?

• 1 INDICATIONS AND USAGE NESINA is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus [see Clinical Studies (14) ]. NESINA is a dipeptidyl peptidase-4 (DPP-4) inhibitor indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes mellitus. ( 1. ) Limitations of Use: Should not be used in patients with type 1 diabetes. ( 1 ) Limitations of Use NESINA should not be used in patients with type 1 diabetes mellitus.

References: https://open.fda.gov/